RACHEL HARVEY: Open Payments
NPI 1912373846 · WARNER ROBINS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$399 in 21 payments from 15 companies in 2025. Trend: 2023 $852 · 2024 $232 · 2025 $399
Food & beverage: $399
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $82 |
| Merck Sharp & Dohme LLC | 2 | $42 |
| Novo Nordisk Inc | 2 | $37 |
| Amgen Inc. | 2 | $30 |
| Janssen Pharmaceuticals, Inc | 1 | $24 |
| PFIZER INC. | 1 | $23 |
| Lundbeck LLC | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| Lilly USA, LLC | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
Products named: LINZESS, GARDASIL 9, REXULTI, OTEZLA, SPRAVATO, VYNDAQEL, VIBERZI, AIRSUPRA.
Industry payments across GA — which companies pay providers there.
